Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome (MB-IBS-EAT)
Primary Purpose
Abdominal Pain, Irritable Bowel Syndrome, IBS
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dietary intervention
Irritable Bowel Syndrome eating awareness training
Sponsored by
About this trial
This is an interventional treatment trial for Abdominal Pain focused on measuring FODMAP Diet, Bowel Habit, Rome IV Criteria, Mindfulness, Abdominal pain, Irritable Bowel Syndrome
Eligibility Criteria
Inclusion criteria:
- Subjects aged 18 and over
- Meet Rome III criteria for diagnosis of Irritable Bowel Syndrome
- Subjects with legal and mental capacity to understand and sign an informed consent.
Exclusion criteria: The following subjects will be excluded from the study:
- Pregnant patients
- Subjects with active malignancy in the previous five years
- Current or prior history of alcohol or drug abuse
- Any history of eating disorder such as anorexia or bulimia
- Subjects taking yoga or with prior history of mindfulness therapy within 3 months of enrolment
- Subjects currently on a FODMAP diet.
- Patients with psychiatric illnesses other than depression or anxiety disorder
Sites / Locations
- University of Miami
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
FODMAPs CONTROL arm
MB-IBS-EAT INTERVENTION STUDY arm
Arm Description
Dietary intervention in this cohort with irritable bowel syndrome will be administered a low Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols diet by a dietician.
Irritable Bowel Syndrome eating awareness training intervention will be started in a comprehensive 8 weekly sessions of Mindfulness eating training.
Outcomes
Primary Outcome Measures
Change in Global Improvement Scale score
This questionnaire provides an overall assessment of how much a patient's symptoms and behaviors have improved or worsened since the start of treatment.
Secondary Outcome Measures
Change in score of IBS-Quality of Life questionnaire
This questionnaire is a 34-item instrument developed and validated for measurement of health-related quality of life in non-subtyped IBS patients. [doi: 10.1186/1477-7525-11-208]
Change in score of Irritable Bowel Syndrome - Severity Scoring System
"This scale evaluates primarily the intensity of IBS symptoms during a 10-day period: abdominal pain, distension, stool frequency and consistency, and interference with life in general. The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100." [doi:10.1038/ajg.2011.201]
Change in score in Perceived Stress Scale
This questionnaire measures the degree to which situations in one's life are appraised as stressful.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02681666
Brief Title
Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome
Acronym
MB-IBS-EAT
Official Title
A Pilot, Randomized Trial of Mindfulness-based Irritable Bowel Syndrome Eating Awareness Training as Compared to the Standard Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Patients With IBS
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
July 1, 2017 (Actual)
Primary Completion Date
December 26, 2017 (Actual)
Study Completion Date
December 26, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Miami
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study will be a randomized parallel trial comparing Mindfulness-Based Irritable Bowel Syndrome Eating Awareness Training done over an 8 week period to a standard low Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols diet.
Detailed Description
This study is supported by findings that Irritable Bowel Syndrome patients have an alteration of the hypothalamus-pituitary-adrenal stress axis such that cortisol levels are elevated. Stress-induced release of corticotropin-releasing factor alters gastric digestion and gastrointestinal motility. Furthermore, stress is a contributing factor to the immune activation and low-grade inflammation observed in Irritable Bowel Syndrome with overall physical and psychological distress correlating with percentage of activated natural killer and T cells. In addition, the brain-gut axis is a proposed mechanism in Irritable Bowel Syndrome due to dysregulated enteric nervous system and central nervous system events. The central nervous system may perceive visceral stimuli from the gut mucosa when inflammation or injury causes afferent nerve sensitization.
Regardless of the specific pathophysiologic basis of Irritable Bowel Syndrome, the current aim of treatment is to improve quality of life, treatments include dietary alterations and psychological therapy such as cognitive behavioral therapy to aid symptomatic relief. The most common dietary intervention in patients with Irritable Bowel Syndrome is the fermentable oligosaccharide, disaccharide, monosaccharide and polyol restricted diet. However, adherence to this diet is very difficult with most patients with Irritable Bowel Syndrome failing to continue eliminating foods leading to bloating or pain. Various psychological therapies have been implemented in the past with the most successful of these being cognitive behavioral therapy. The beneficial results of incorporating mindfulness-based interventions to improve myriad health-related problems, such as Irritable Bowel Syndrome, anxiety disorders , psychological distress, quality of life, depression fibromyalgia , diabetes , and eating disorders has grown considerably in the recent past. Mindfulness Based Eating Awareness Training, which was developed based on Jon Kabat-Zinn's Mindfulness Based Stress Reduction program, has been shown to improve binge eating disorder and other food and stress-related problems. The effect of Mindfulness Based Eating Awareness Training is driven by the improved ability of practitioners to increase engagement in non-judgmental self-awareness behaviors designed to improve regulatory impulses and stress reactivity as well as to nurture awareness of emotional status and outside triggers. The investigators have developed a 12 week Mindfulness-Based Irritable Bowel Syndrome Eating Awareness Training inspired by relevant pieces of the Mindfulness Based Eating Awareness Training program. Mindfulness based interventions integrate moment by moment awareness of bodily sensations, observations, thoughts, and feelings while suspending judgments of self. Successful Irritable Bowel Syndrome treatment modalities have been elusive, but have a strong food and stress-reactive association making this medical condition ideal for a mindfulness treatment intervention. The usual diet for Irritable Bowel Syndrome is an elimination diet of fermentable carbohydrates (of varying sugar lengths) and polyols (sugar alcohols and stone fruits) called the Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols elimination diet. Patients with Irritable Bowel Syndrome who follow a Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols diet receive suboptimal nutrient intake over long time periods while attempting to discern which food groups are digestible and which others are intolerable, with mixed findings of improvement in quality of life, and other stress-related measures.
After eligibility is established, written informed consent will be obtained and randomization will be conducted to place participants in either the mindfulness-based Irritable Bowel Syndrome- eating awareness training group or the Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols group and pre-baseline testing will be performed on both groups. Two-four weeks later participants will receive baseline testing at their first session of both arms of the study. Four weeks later, participants in both study arms will receive a follow up assessment testing. Directly following the eight week intervention or Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols arm, participants will receive post-intervention testing 1.
At 2 and 4 weeks following the intervention or Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols FODMAPs) arm, post-intervention testing 2 and post-intervention testing 3 will take place, respectively for a total of 12 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Abdominal Pain, Irritable Bowel Syndrome, IBS
Keywords
FODMAP Diet, Bowel Habit, Rome IV Criteria, Mindfulness, Abdominal pain, Irritable Bowel Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FODMAPs CONTROL arm
Arm Type
Active Comparator
Arm Description
Dietary intervention in this cohort with irritable bowel syndrome will be administered a low Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols diet by a dietician.
Arm Title
MB-IBS-EAT INTERVENTION STUDY arm
Arm Type
Experimental
Arm Description
Irritable Bowel Syndrome eating awareness training intervention will be started in a comprehensive 8 weekly sessions of Mindfulness eating training.
Intervention Type
Dietary Supplement
Intervention Name(s)
Dietary intervention
Other Intervention Name(s)
FODMAPs Diet
Intervention Description
Sessions will be spent with patients discussing the FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet and how to use this diet to treat their Irritable Bowel Syndrome.
Intervention Type
Behavioral
Intervention Name(s)
Irritable Bowel Syndrome eating awareness training
Other Intervention Name(s)
MB-IBS-EAT
Intervention Description
A type of meditation about their eating habits.
Primary Outcome Measure Information:
Title
Change in Global Improvement Scale score
Description
This questionnaire provides an overall assessment of how much a patient's symptoms and behaviors have improved or worsened since the start of treatment.
Time Frame
Baseline, 4 weeks, 8 weeks, 12 weeks
Secondary Outcome Measure Information:
Title
Change in score of IBS-Quality of Life questionnaire
Description
This questionnaire is a 34-item instrument developed and validated for measurement of health-related quality of life in non-subtyped IBS patients. [doi: 10.1186/1477-7525-11-208]
Time Frame
Baseline, 4 weeks, 8 weeks, 12 weeks
Title
Change in score of Irritable Bowel Syndrome - Severity Scoring System
Description
"This scale evaluates primarily the intensity of IBS symptoms during a 10-day period: abdominal pain, distension, stool frequency and consistency, and interference with life in general. The IBS-SSS calculates the sum of these 5 items each scored on a visual analog scale from 0 to 100." [doi:10.1038/ajg.2011.201]
Time Frame
Baseline, 4 weeks, 8 weeks, 12 weeks
Title
Change in score in Perceived Stress Scale
Description
This questionnaire measures the degree to which situations in one's life are appraised as stressful.
Time Frame
Baseline, 4 weeks, 8 weeks, 12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Subjects aged 18 and over
Meet Rome III criteria for diagnosis of Irritable Bowel Syndrome
Subjects with legal and mental capacity to understand and sign an informed consent.
Exclusion criteria: The following subjects will be excluded from the study:
Pregnant patients
Subjects with active malignancy in the previous five years
Current or prior history of alcohol or drug abuse
Any history of eating disorder such as anorexia or bulimia
Subjects taking yoga or with prior history of mindfulness therapy within 3 months of enrolment
Subjects currently on a FODMAP diet.
Patients with psychiatric illnesses other than depression or anxiety disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Sussman, MD
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Miami
City
Miami
State/Province
Florida
ZIP/Postal Code
33136
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome
We'll reach out to this number within 24 hrs